V. Ram Peddi - Concepedia

Author

V. Ram Peddi

California Pacific Medical Center

Also Known As

V Ram Peddi, V. Ram Peddi, V. ram Peddi, V.Ram Peddi, VR Peddi, Venkat Ram Peddi

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

California Pacific Medical Center University of Cincinnati University of Cincinnati Medical Center University of California, San Francisco Astellas Pharma (United States)

About

V. Ram Peddi is an author at California Pacific Medical Center specializing in medicine, urology, and kidney transplant.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	277
2	Nephrology	5	5	261
3	Immunology	2	2	86
4	Gastroenterology	1	1	16
5	Pathology	1	1	70

V. Ram Peddi

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Alemtuzumab Induction in Renal Transplantation Michael J. Hanaway, E. Steve Woodle, Shamkant Mulgaonkar, New England Journal of Medicine	2011	374
RECURRENT AND DE NOVO GLOMERULAR DISEASE AFTER RENAL TRANSPLANTATION Sundaram Hariharan, Mark B. Adams, Daniel C. Brennan, Transplantation	1999	234
Recurrent and de novo renal diseases after renal transplantation: A report from the renal allograft disease registry Sundaram Hariharan, V. Ram Peddi, C.P. Johnson, American Journal of Kidney Diseases GlomerulonephritisRenal DiseasesUrologyTransplantationKidney Transplant	1998	130
Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on cd3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients V. Ram Peddi, M. Ann Bryant, Prabir Roy‐Chaudhury, Transplantation	2002	114
Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study Joseph F. Buell, Lucy Lee, Jill Martin, Clinical Transplantation	2004	74
A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin<sup>®</sup> in living‐donor kidney transplantation E. Steve Woodle, V. Ram Peddi, Stephen Tomlanovich, Clinical Transplantation	2009	71
Disseminated histoplasmosis in renal allograft recipients V. Ram Peddi, Sundaram Hariharan, M. Roy First Clinical Transplantation Diagnostic MycologyUrologyTransplantationMolecular Diagnostic TechniquesKidney Transplant	1996	70
A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor Flavio Vincenti, Klemens Budde, Pierre Merville, American Journal of Transplantation	2018	57
An open‐label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency V. Ram Peddi, Stephen C. Jensik, Mark D. Pescovitz, Clinical Transplantation	2004	40
Altered balance between effector T cells and FOXP3<sup>+</sup>HELIOS<sup>+</sup>regulatory T cells after thymoglobulin induction in kidney transplant recipients Qizhi Tang, Joey Leung, Kristin Melli, Transplant International	2012	39

Page 1